There have been 50 recent insider transactions recorded for Lumos Pharma, Inc. (LUMO), including 26 buys and 24 sells. Total insider buying was valued at $1.45M and total insider selling at $956.02K.
Notable insiders with recent activity include Pitukcheewanont Pisit Duke, Mckew John C., Lawley Lori D. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — LUMO
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2024-07-01 |
Pitukcheewanont Pisit Duke |
Chief Medical Officer |
Disposition |
25,500 |
$3.30 |
$84.15K |
- |
| 2024-02-01 |
Pitukcheewanont Pisit Duke |
Chief Medical Officer |
Disposition |
3,333 |
$3.52 |
$11.73K |
- |
| 2024-01-04 |
Pitukcheewanont Pisit Duke |
Chief Medical Officer |
Disposition |
- |
- |
- |
10,930 |
| 2023-08-02 |
Mckew John C. |
Chief Scientific Officer |
Informative Sell |
3,407 |
$3.21 |
$10.92K |
18,707 |
| 2023-08-01 |
Mckew John C. |
Chief Scientific Officer |
Tax Withholding of RSU |
1,593 |
$3.28 |
$5.23K |
22,114 |
| 2023-08-01 |
Lawley Lori D |
Chief Financial Officer |
Tax Withholding of RSU |
229 |
$3.28 |
$751.12 |
11,502 |
| 2023-06-01 |
Pitukcheewanont Pisit Duke |
Chief Medical Officer |
Disposition |
29,750 |
$7.69 |
$228.78K |
- |
| 2023-05-10 |
Zoth Lota S. |
Director |
RSU Award |
3,345 |
$3.42 |
$11.44K |
3,345 |
| 2023-05-10 |
Raffin Thomas A. |
Director |
RSU Award |
3,345 |
$3.42 |
$11.44K |
3,345 |
| 2023-05-10 |
Lalande Kevin M. |
Director |
RSU Award |
3,345 |
$3.42 |
$11.44K |
3,345 |
| 2023-05-10 |
Mccracken Joseph S |
Director |
RSU Award |
3,345 |
$3.42 |
$11.44K |
3,345 |
| 2023-05-10 |
Johnson Chad Allen |
Director |
RSU Award |
3,345 |
$3.42 |
$11.44K |
3,345 |
| 2023-05-10 |
Van Es-johansson An |
Director |
RSU Award |
3,345 |
$3.42 |
$11.44K |
3,345 |
| 2023-04-04 |
Mckew John C. |
Chief Scientific Officer |
Informative Sell |
2,214 |
$3.27 |
$7.24K |
23,207 |
| 2023-04-01 |
Hawkins Richard J |
Chief Executive Officer |
Tax Withholding of RSU |
1,522 |
$3.31 |
$5.04K |
750,805 |
| 2023-04-01 |
Mckew John C. |
Chief Scientific Officer |
Tax Withholding of RSU |
1,036 |
$3.31 |
$3.43K |
25,421 |
| 2023-04-01 |
Lawley Lori D |
Chief Financial Officer |
Tax Withholding of RSU |
274 |
$3.31 |
$906.94 |
11,231 |
| 2023-04-01 |
Powers Bradley J |
General Counsel |
Tax Withholding of RSU |
342 |
$3.31 |
$1.13K |
5,989 |
| 2023-02-02 |
Mckew John C. |
Chief Scientific Officer |
Informative Sell |
439 |
$3.53 |
$1.55K |
26,457 |
| 2023-02-01 |
Hawkins Richard J |
Chief Executive Officer |
RSU Award |
35,400 |
$3.52 |
$124.61K |
35,400 |
| 2023-02-01 |
Karpf David B |
Chief Medical Officer |
Tax Withholding of RSU |
36 |
$3.52 |
$126.72 |
8,294 |
| 2023-02-01 |
Mckew John C. |
Chief Scientific Officer |
RSU Award |
16,000 |
$3.52 |
$56.32K |
16,000 |
| 2023-02-01 |
Schuchart Aaron |
Chief Business Officer |
Tax Withholding of RSU |
104 |
$3.52 |
$366.08 |
5,381 |
| 2023-02-01 |
Lawley Lori D |
Chief Financial Officer |
Tax Withholding of RSU |
114 |
$3.52 |
$401.28 |
11,505 |
| 2023-02-01 |
Powers Bradley J |
General Counsel |
Tax Withholding of RSU |
131 |
$3.52 |
$461.12 |
6,331 |
| 2022-11-16 |
Mccracken Joseph S |
Director |
Informative Buy |
4,000 |
$5.03 |
$20.12K |
15,721 |
| 2022-09-23 |
Hawkins Richard J |
Chief Executive Officer |
Informative Buy |
208 |
$8.80 |
$1.83K |
4,469 |
| 2022-09-21 |
Hawkins Richard J |
Chief Executive Officer |
Informative Buy |
2,214 |
$8.84 |
$19.57K |
4,261 |
| 2022-09-20 |
Hawkins Richard J |
Chief Executive Officer |
Informative Buy |
1,506 |
$8.75 |
$13.18K |
2,047 |
| 2022-09-19 |
Hawkins Richard J |
Chief Executive Officer |
Informative Buy |
541 |
$8.65 |
$4.68K |
541 |
| 2022-09-01 |
Karpf David B |
Chief Medical Officer |
Disposition |
42,500 |
$10.93 |
$464.53K |
- |
| 2022-02-16 |
Van Es-johansson An |
Director |
Disposition |
5,729 |
$17.86 |
$102.32K |
- |
| 2022-02-01 |
Karpf David B |
Chief Medical Officer |
RSU Award |
5,000 |
$10.02 |
$50.1K |
5,000 |
| 2022-02-01 |
Mckew John C. |
Chief Scientific Officer |
RSU Award |
14,000 |
$10.02 |
$140.28K |
14,000 |
| 2022-02-01 |
Schuchart Aaron |
Chief Business Officer |
Tax Withholding of RSU |
52 |
$10.02 |
$521.04 |
3,985 |
| 2022-02-01 |
Lawley Lori D |
Chief Financial Officer |
Tax Withholding of RSU |
65 |
$10.02 |
$651.30 |
10,122 |
| 2022-02-01 |
Powers Bradley J |
General Counsel |
Tax Withholding of RSU |
78 |
$10.02 |
$781.56 |
5,904 |
| 2021-09-08 |
Lalande Kevin M. |
Director |
Informative Buy |
10,000 |
$11.21 |
$112.12K |
730,446 |
| 2021-09-08 |
Mckew John C. |
Chief Scientific Officer |
Informative Sell |
2,214 |
$11.30 |
$25.02K |
31,012 |
| 2021-09-07 |
Lalande Kevin M. |
Director |
Informative Buy |
10,000 |
$11.11 |
$111.14K |
720,446 |
| 2021-09-03 |
Lalande Kevin M. |
Director |
Informative Buy |
8,100 |
$11.35 |
$91.91K |
710,446 |
| 2021-09-02 |
Lalande Kevin M. |
Director |
Informative Buy |
6,300 |
$11.23 |
$70.74K |
702,346 |
| 2021-09-01 |
Lalande Kevin M. |
Director |
Informative Buy |
4,589 |
$10.87 |
$49.89K |
696,046 |
| 2021-09-01 |
Karpf David B |
Chief Medical Officer |
Disposition |
- |
- |
- |
7,500 |
| 2021-08-31 |
Lalande Kevin M. |
Director |
Informative Buy |
6,000 |
$10.70 |
$64.18K |
691,457 |
| 2021-08-30 |
Lalande Kevin M. |
Director |
Informative Buy |
8,625 |
$10.52 |
$90.74K |
685,457 |
| 2021-08-27 |
Lalande Kevin M. |
Director |
Informative Buy |
4,981 |
$10.50 |
$52.28K |
677,832 |
| 2021-08-26 |
Lalande Kevin M. |
Director |
Informative Buy |
6,200 |
$10.07 |
$62.43K |
672,851 |
| 2021-08-25 |
Lalande Kevin M. |
Director |
Informative Buy |
14,900 |
$9.87 |
$147.08K |
666,651 |
| 2021-08-24 |
Lalande Kevin M. |
Director |
Informative Buy |
10,775 |
$9.45 |
$101.87K |
651,751 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry